Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Diabetes, Obesity & Metabolism|August 2, 2008
Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT)A M Sharma, I D Caterson, W Coutinho, et al.
European Heart Journal|February 25, 2005
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidityK Malmberg, L Rydén, H Wedel, et al.
International Journal of Cardiology. Heart & Vasculature|October 19, 2020
Incidence of acute myocardial infarction-related cardiogenic shock during corona virus disease 19 (COVID-19) pandemicM D Lauridsen, J H Butt, L Østergaard, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 23, 2017
Gender differences in the effects of cardiovascular drugsJ Tamargo, G Rosano, T Walther, et al.
Diabetes, Obesity & Metabolism|September 18, 2009
Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trialL F Van Gaal, I D Caterson, W Coutinho, et al.
Diabetologia|May 11, 2010
Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction--a nationwide studyM L Norgaard, S S Andersen, T K Schramm, et al.
Public Health|January 17, 2022
Return to work after COVID-19 infection - A Danish nationwide registry studyP A Jacobsen, M P Andersen, G Gislason, et al.
International Journal of Obesity (2005)|December 19, 2014
Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trialR V Seimon, D Espinoza, N Finer, et al.
Journal of Internal Medicine|January 15, 2009
Clinical consequences of hospital variation in use of oral anticoagulant therapy after first-time admission for atrial fibrillationM L Hansen, N Gadsbøll, S Rasmussen, et al.
Diabetes, Obesity & Metabolism|December 24, 2011
Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trialI D Caterson, N Finer, W Coutinho, et al.
Pageof 15